ALDH1A2 (RALDH2) genetic variation in human congenital heart disease
<p>Abstract</p> <p>Background</p> <p>Signaling by the vitamin A-derived morphogen retinoic acid (RA) is required at multiple steps of cardiac development. Since conversion of retinaldehyde to RA by retinaldehyde dehydrogenase type II (ALDH1A2, a.k.a RALDH2) is critical...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-11-01
|
| Series: | BMC Medical Genetics |
| Online Access: | http://www.biomedcentral.com/1471-2350/10/113 |
| _version_ | 1819280642959998976 |
|---|---|
| author | Mesquita Sonia MF Marques Lívia P Vasconcelos Michelle Cravo Roberta M Sobreira Tiago J Silva Fábio A Ruiz Viviane F Pavan Marilene Krieger José E Lopes Antônio AB Oliveira Paulo S Pereira Alexandre C Xavier-Neto José |
| author_facet | Mesquita Sonia MF Marques Lívia P Vasconcelos Michelle Cravo Roberta M Sobreira Tiago J Silva Fábio A Ruiz Viviane F Pavan Marilene Krieger José E Lopes Antônio AB Oliveira Paulo S Pereira Alexandre C Xavier-Neto José |
| author_sort | Mesquita Sonia MF |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Signaling by the vitamin A-derived morphogen retinoic acid (RA) is required at multiple steps of cardiac development. Since conversion of retinaldehyde to RA by retinaldehyde dehydrogenase type II (ALDH1A2, a.k.a RALDH2) is critical for cardiac development, we screened patients with congenital heart disease (CHDs) for genetic variation at the ALDH1A2 locus.</p> <p>Methods</p> <p>One-hundred and thirty-three CHD patients were screened for genetic variation at the ALDH1A2 locus through bi-directional sequencing. In addition, six SNPs (rs2704188, rs1441815, rs3784259, rs1530293, rs1899430) at the same locus were studied using a TDT-based association approach in 101 CHD trios. Observed mutations were modeled through molecular mechanics (MM) simulations using the AMBER 9 package, Sander and Pmemd programs. Sequence conservation of observed mutations was evaluated through phylogenetic tree construction from ungapped alignments containing ALDH8 s, ALDH1Ls, ALDH1 s and ALDH2 s. Trees were generated by the Neighbor Joining method. Variations potentially affecting splicing mechanisms were cloned and functional assays were designed to test splicing alterations using the pSPL3 splicing assay.</p> <p>Results</p> <p>We describe in Tetralogy of Fallot (TOF) the mutations Ala151Ser and Ile157Thr that change non-polar to polar residues at exon 4. Exon 4 encodes part of the highly-conserved tetramerization domain, a structural motif required for ALDH oligomerization. Molecular mechanics simulation studies of the two mutations indicate that they hinder tetramerization. We determined that the SNP rs16939660, previously associated with spina bifida and observed in patients with TOF, does not affect splicing. Moreover, association studies performed with classical models and with the transmission disequilibrium test (TDT) design using single marker genotype, or haplotype information do not show differences between cases and controls.</p> <p>Conclusion</p> <p>In summary, our screen indicates that ALDH1A2 genetic variation is present in TOF patients, suggesting a possible causal role for this gene in rare cases of human CHD, but does not support the hypothesis that variation at the ALDH1A2 locus is a significant modifier of the risk for CHD in humans.</p> |
| first_indexed | 2024-12-24T00:47:03Z |
| format | Article |
| id | doaj.art-00bc3cbd9fe34d3e91f4576bc2ac2685 |
| institution | Directory Open Access Journal |
| issn | 1471-2350 |
| language | English |
| last_indexed | 2024-12-24T00:47:03Z |
| publishDate | 2009-11-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Medical Genetics |
| spelling | doaj.art-00bc3cbd9fe34d3e91f4576bc2ac26852022-12-21T17:23:45ZengBMCBMC Medical Genetics1471-23502009-11-0110111310.1186/1471-2350-10-113ALDH1A2 (RALDH2) genetic variation in human congenital heart diseaseMesquita Sonia MFMarques Lívia PVasconcelos MichelleCravo Roberta MSobreira Tiago JSilva Fábio ARuiz Viviane FPavan MarileneKrieger José ELopes Antônio ABOliveira Paulo SPereira Alexandre CXavier-Neto José<p>Abstract</p> <p>Background</p> <p>Signaling by the vitamin A-derived morphogen retinoic acid (RA) is required at multiple steps of cardiac development. Since conversion of retinaldehyde to RA by retinaldehyde dehydrogenase type II (ALDH1A2, a.k.a RALDH2) is critical for cardiac development, we screened patients with congenital heart disease (CHDs) for genetic variation at the ALDH1A2 locus.</p> <p>Methods</p> <p>One-hundred and thirty-three CHD patients were screened for genetic variation at the ALDH1A2 locus through bi-directional sequencing. In addition, six SNPs (rs2704188, rs1441815, rs3784259, rs1530293, rs1899430) at the same locus were studied using a TDT-based association approach in 101 CHD trios. Observed mutations were modeled through molecular mechanics (MM) simulations using the AMBER 9 package, Sander and Pmemd programs. Sequence conservation of observed mutations was evaluated through phylogenetic tree construction from ungapped alignments containing ALDH8 s, ALDH1Ls, ALDH1 s and ALDH2 s. Trees were generated by the Neighbor Joining method. Variations potentially affecting splicing mechanisms were cloned and functional assays were designed to test splicing alterations using the pSPL3 splicing assay.</p> <p>Results</p> <p>We describe in Tetralogy of Fallot (TOF) the mutations Ala151Ser and Ile157Thr that change non-polar to polar residues at exon 4. Exon 4 encodes part of the highly-conserved tetramerization domain, a structural motif required for ALDH oligomerization. Molecular mechanics simulation studies of the two mutations indicate that they hinder tetramerization. We determined that the SNP rs16939660, previously associated with spina bifida and observed in patients with TOF, does not affect splicing. Moreover, association studies performed with classical models and with the transmission disequilibrium test (TDT) design using single marker genotype, or haplotype information do not show differences between cases and controls.</p> <p>Conclusion</p> <p>In summary, our screen indicates that ALDH1A2 genetic variation is present in TOF patients, suggesting a possible causal role for this gene in rare cases of human CHD, but does not support the hypothesis that variation at the ALDH1A2 locus is a significant modifier of the risk for CHD in humans.</p>http://www.biomedcentral.com/1471-2350/10/113 |
| spellingShingle | Mesquita Sonia MF Marques Lívia P Vasconcelos Michelle Cravo Roberta M Sobreira Tiago J Silva Fábio A Ruiz Viviane F Pavan Marilene Krieger José E Lopes Antônio AB Oliveira Paulo S Pereira Alexandre C Xavier-Neto José ALDH1A2 (RALDH2) genetic variation in human congenital heart disease BMC Medical Genetics |
| title | ALDH1A2 (RALDH2) genetic variation in human congenital heart disease |
| title_full | ALDH1A2 (RALDH2) genetic variation in human congenital heart disease |
| title_fullStr | ALDH1A2 (RALDH2) genetic variation in human congenital heart disease |
| title_full_unstemmed | ALDH1A2 (RALDH2) genetic variation in human congenital heart disease |
| title_short | ALDH1A2 (RALDH2) genetic variation in human congenital heart disease |
| title_sort | aldh1a2 raldh2 genetic variation in human congenital heart disease |
| url | http://www.biomedcentral.com/1471-2350/10/113 |
| work_keys_str_mv | AT mesquitasoniamf aldh1a2raldh2geneticvariationinhumancongenitalheartdisease AT marquesliviap aldh1a2raldh2geneticvariationinhumancongenitalheartdisease AT vasconcelosmichelle aldh1a2raldh2geneticvariationinhumancongenitalheartdisease AT cravorobertam aldh1a2raldh2geneticvariationinhumancongenitalheartdisease AT sobreiratiagoj aldh1a2raldh2geneticvariationinhumancongenitalheartdisease AT silvafabioa aldh1a2raldh2geneticvariationinhumancongenitalheartdisease AT ruizvivianef aldh1a2raldh2geneticvariationinhumancongenitalheartdisease AT pavanmarilene aldh1a2raldh2geneticvariationinhumancongenitalheartdisease AT kriegerjosee aldh1a2raldh2geneticvariationinhumancongenitalheartdisease AT lopesantonioab aldh1a2raldh2geneticvariationinhumancongenitalheartdisease AT oliveirapaulos aldh1a2raldh2geneticvariationinhumancongenitalheartdisease AT pereiraalexandrec aldh1a2raldh2geneticvariationinhumancongenitalheartdisease AT xaviernetojose aldh1a2raldh2geneticvariationinhumancongenitalheartdisease |